CCM Investment Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.5M | Sell |
16,878
-236
| -1% | -$239K | 1.49% | 28 |
|
|
2025
Q4 | $18.4M | Sell |
17,114
-402
| -2% | -$384K | 1.76% | 20 |
|
|
2025
Q3 | $13.4M | Buy |
17,516
+194
| +1% | +$144K | 1.32% | 38 |
|
|
2025
Q2 | $13.5M | Buy |
17,322
+1,531
| +10% | +$1.19M | 1.45% | 32 |
|
|
2025
Q1 | $13M | Buy |
15,791
+3,456
| +28% | +$2.88M | 1.6% | 36 |
|
|
2024
Q4 | $9.52M | Sell |
12,335
-2,579
| -17% | -$2.14M | 1.05% | 49 |
|
|
2024
Q3 | $13.2M | Buy |
14,914
+172
| +1% | +$155K | 1.47% | 39 |
|
|
2024
Q2 | $13.3M | Buy |
14,742
+137
| +0.9% | +$110K | 1.57% | 32 |
|
|
2024
Q1 | $11.4M | Buy |
14,605
+13,534
| +1,264% | +$9.63M | 1.36% | 42 |
|
|
2023
Q4 | $624K | Buy |
1,071
+55
| +5% | +$32.1K | 0.08% | 65 |
|
|
2023
Q3 | $546K | Hold |
1,016
| – | – | 0.08% | 60 |
|
|
2023
Q2 | $476K | Sell |
1,016
-200
| -16% | -$83.9K | 0.06% | 61 |
|
|
2023
Q1 | $418K | Sell |
1,216
-15
| -1% | -$5.06K | 0.06% | 62 |
|
|
2022
Q4 | $450K | Sell |
1,231
-189
| -13% | -$67K | 0.07% | 61 |
|
|
2022
Q3 | $459K | Sell |
1,420
-55
| -4% | -$17.4K | 0.08% | 58 |
|
|
2022
Q2 | $478K | Hold |
1,475
| – | – | 0.08% | 58 |
|
|
2022
Q1 | $422K | Sell |
1,475
-2,030
| -58% | -$522K | 0.06% | 60 |
|
|
2021
Q4 | $968K | Sell |
3,505
-2,000
| -36% | -$507K | 0.12% | 56 |
|
|
2021
Q3 | $1.27M | Hold |
5,505
| – | – | 0.17% | 59 |
|
|
2021
Q2 | $1.26M | Sell |
5,505
-4,000
| -42% | -$803K | 0.16% | 57 |
|
|
2021
Q1 | $1.77M | Hold |
9,505
| – | – | 0.24% | 57 |
|
|
2020
Q4 | $1.6M | Sell |
9,505
-1
| -0% | -$149 | 0.23% | 56 |
|
|
2020
Q3 | $1.41M | Sell |
9,506
-144
| -1% | -$22.3K | 0.23% | 56 |
|
|
2020
Q2 | $1.58M | Sell |
9,650
-175
| -2% | -$26.9K | 0.27% | 55 |
|
|
2020
Q1 | $1.36M | Sell |
9,825
-3,415
| -26% | -$469K | 0.27% | 53 |
|
|
2019
Q4 | $1.74M | Sell |
13,240
-125
| -0.9% | -$14.5K | 0.27% | 53 |
|
|
2019
Q3 | $1.49M | Sell |
13,365
-90,582
| -87% | -$10.1M | 0.25% | 54 |
|
|
2019
Q2 | $11.5M | Sell |
103,947
-8,098
| -7% | -$954K | 1.94% | 20 |
|
|
2019
Q1 | $14.5M | Sell |
112,045
-5,678
| -5% | -$690K | 2.44% | 7 |
|
|
2018
Q4 | $13.6M | Buy |
117,723
+10,264
| +10% | +$1.15M | 2.71% | 5 |
|
|
2018
Q3 | $11.5M | Buy |
107,459
+39,290
| +58% | +$3.93M | 2.13% | 14 |
|
|
2018
Q2 | $5.82M | Buy |
+68,169
| New | +$5.6M | 1.11% | 43 |
|
Other funds holding LLY
VCM
VPM
CCM Investment Advisers's LLY Position: Q1 2026 in Review
CCM Investment Advisers reduced its Eli Lilly (LLY) stake by 1.4% in Q1 2026, selling an estimated $239K and leaving 16,878 shares worth $15.5M. The position accounts for 1.49% of the portfolio, ranked #28.
CCM Investment Advisers first reported a position in LLY in Q2 2018 and has held it in 32 quarters since. The position peaked at $18.4M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- CCM Investment Advisers held 16,878 shares of Eli Lilly worth $15.5M as of Q1 2026.
- CCM Investment Advisers sold 236 Eli Lilly shares in Q1 2026, an estimated $239K.
- Eli Lilly made up 1.49% of CCM Investment Advisers's portfolio in Q1 2026, its #28 holding.
- CCM Investment Advisers first reported a position in Eli Lilly in Q2 2018 and has held it in 32 quarters since.
- CCM Investment Advisers's Eli Lilly position peaked at $18.4M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on CCM Investment Advisers's 13F filing for Q1 2026, filed 20 May 2026.